The year started with a big gap down in all stock indexes and a reminder that “oversold” and “diversified” mean little during forced liquidations. Crude oil dived lower and it took all stocks with it. The 3X inverse crude oil ETF DWTI (NYSE:DWT) went from $200 to $400 in three weeks. The small-cap biotech ETF, SPDR S&P Biotech (NYSE:XBI) was absolutely obliterated and lost 38%.
February
There was a major momentum divergence in U.S. market indexes which marked the bottom in U.S. indexes. Emerging markets had already bottomed in late January. Gold and silver miners showed notable relative strength early in the month and were massive outperformers during the market recovery. Small-cap miners like CDE (NYSE:CDE) went from $2 to $16 in six months.
March
You don’t have to catch the exact bottom in order to benefit from a market recovery. You can wait a few weeks to see a confirmation of a new uptrend and still do incredible well as more and more sectors join a rally. Emerging markets began a huge rally in early March. The 3X long Brazil ETF (NYSE:BRZU), BRZU went from $10 to $50 in in the following six months.
April
The biotech sector finally joined the bull party. Small caps started to outperform large caps.
May
The first major pullback to a rising 50-day moving average was ferociously bought.
June
Brexit surprised the market. It led to a quick two-day crash, followed by just as quick and impressive snapback. The recovery in the large-cap tech ETF was especially striking. QQQ (NASDAQ:QQQ) was at new year-to-date highs two weeks after the Brexit correction.
July
A major technical breakout in the semiconductor sector. Even if you missed the first six months of the year, July was not too late to join the market rally.
August
The market is in a good mood. Recent IPOs like ACIA (NASDAQ:ACIA) are reaching for the sky. One of the most powerful setups is a hot recent IPO and a bull market.
September
Amazon (NASDAQ:AMZN) reached new all-time highs, cementing its place as one of the most incredible stock market stories. $1000 invested in AMZN on its IPO day in 1997 is worth about $440,000 in 2016. The little detail is that Amazon had a 90% drawdown in 2000.
October
The biotech sector rolls over as the market fears the potential impact of a Clinton’s administration on drug regulations and prices.
November
Donald Trump wins the U.S. presidential elections. The stock market goes limit down the night of the elections. Then, it stages one of the most massive short-term rallies in its recent history. Interest rates skyrocket. Financials break out and don’t look back.
December
New lows in volatility. The inverse volatility ETF, XIV (NASDAQ:XIV) triples from its lows in February, 2016.
